Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M312,453Revenue (TTM) $M71,595Net Margin (%)22.0Altman Z-Score5.2
Enterprise Value $M298,657EPS (TTM) $5.7Operating Margin %27.5Piotroski F-Score8
P/E(ttm)20.3Beneish M-Score-2.5Pre-tax Margin (%)26.9Higher ROA y-yY
Price/Book4.310-y EBITDA Growth Rate %4.2Quick Ratio2.4Cash flow > EarningsY
Price/Sales4.55-y EBITDA Growth Rate %5.9Current Ratio2.7Lower Leverage y-yN
Price/Free Cash Flow23.9y-y EBITDA Growth Rate %6.9ROA % (ttm)11.6Higher Current Ratio y-yY
Dividend Yield %2.7PEG3.4ROE % (ttm)21.9Less Shares Outstanding y-yY
Payout Ratio %54.0Shares Outstanding M2,721ROIC % (ttm)28.9Gross Margin Increase y-yY

Gurus Latest Trades with JNJ

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
JNJKen Fisher 2016-12-31 Add0.02%$110.99 - $120.31
($115.51)
$ 114.20-1%Add 1.03%10,957,134
JNJT Rowe Price Equity Income Fund 2016-12-31 Reduce-0.01%$110.99 - $120.31
($115.51)
$ 114.20-1%Reduce -0.30%3,370,000
JNJTweedy Browne 2016-09-30 Reduce-0.81%$117.27 - $125.4
($121.32)
$ 114.20-6%Reduce -7.39%2,978,783
JNJYacktman Fund 2016-09-30 Reduce-0.69%$117.27 - $125.4
($121.32)
$ 114.20-6%Reduce -11.11%3,200,000
JNJDonald Yacktman 2016-09-30 Reduce-0.53%$117.27 - $125.4
($121.32)
$ 114.20-6%Reduce -7.91%6,143,753
JNJYacktman Focused Fund 2016-09-30 Reduce-0.46%$117.27 - $125.4
($121.32)
$ 114.20-6%Reduce -7.69%1,800,000
JNJJoel Greenblatt 2016-09-30 Add0.32%$117.27 - $125.4
($121.32)
$ 114.20-6%Add 4262.88%214,043
JNJFirst Eagle Investment 2016-09-30 Reduce-0.22%$117.27 - $125.4
($121.32)
$ 114.20-6%Reduce -96.29%28,177
JNJRobert Olstein 2016-09-30 Reduce-0.18%$117.27 - $125.4
($121.32)
$ 114.20-6%Reduce -26.83%30,000
JNJBarrow, Hanley, Mewhinney & Strauss 2016-09-30 Reduce-0.16%$117.27 - $125.4
($121.32)
$ 114.20-6%Reduce -6.63%12,334,416
JNJJohn Paulson 2016-09-30 Reduce-0.12%$117.27 - $125.4
($121.32)
$ 114.20-6%Reduce -72.66%35,000
JNJMichael Price 2016-09-30 Reduce-0.08%$117.27 - $125.4
($121.32)
$ 114.20-6%Reduce -20.00%20,000
JNJRichard Pzena 2016-09-30 Reduce-0.08%$117.27 - $125.4
($121.32)
$ 114.20-6%Reduce -9.13%1,002,314
JNJMario Gabelli 2016-09-30 Reduce-0.01%$117.27 - $125.4
($121.32)
$ 114.20-6%Reduce -5.98%294,127
JNJRuane Cunniff 2016-09-30 Reduce-0.01%$117.27 - $125.4
($121.32)
$ 114.20-6%Reduce -55.83%5,713
JNJCharles Brandes 2016-09-30 Reduce-0.01%$117.27 - $125.4
($121.32)
$ 114.20-6%Reduce -4.88%126,627
JNJT Rowe Price Equity Income Fund 2016-09-30 Reduce-0.01%$117.27 - $125.4
($121.32)
$ 114.20-6%Reduce -0.59%3,380,000
JNJDodge & Cox 2016-09-30 Reduce$117.27 - $125.4
($121.32)
$ 114.20-6%Reduce -0.57%34,985
JNJJohn Rogers 2016-09-30 Add$117.27 - $125.4
($121.32)
$ 114.20-6%Add 0.11%858,549
JNJYacktman Focused Fund 2016-06-30 Reduce-0.87%$108.2 - $121.3
($113.54)
$ 114.201%Reduce -15.22%1,950,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

JNJ is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


JNJ: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
PRINCE CHARLESDirector 2016-10-21Buy875$114.110.08view
Caruso Dominic JExec VP, Finance; CFO 2016-07-26Sell41,146$125.01-8.65view
Kapusta Ronald AController, CAO 2016-07-22Sell2,935$125.01-8.65view
Pruden Gary JExec VP, WW Chair, Med Devices 2016-06-07Sell9,735$116.03-1.58view
Kapusta Ronald AController, CAO 2016-06-07Sell3,000$115.79-1.37view
Kapusta Ronald AController, CAO 2016-05-10Sell3,957$114.77-0.5view
Stoffels PaulusChief Scientific Officer 2016-02-17Sell125,000$102.4311.49view
Fasolo PeterVP, Global Human Resources 2016-02-03Sell151,385$104.129.68view
Ullmann Michael HVP, General Counsel 2015-11-20Sell17,650$102.4711.45view
Caruso Dominic JVP, Finance; CFO 2015-11-02Sell20,569$102.2111.73view

Press Releases about JNJ :

Quarterly/Annual Reports about JNJ:

    News about JNJ:

    Articles On GuruFocus.com
    A Valuation of Johnson & Johnson Jan 17 2017 
    2 Top Health Care Dividend Stocks Jan 12 2017 
    PPL Corp.: Geographically Diversified With 4.4% Yield, Long Dividend History Jan 12 2017 
    Top 7 Dividend Health Care Stocks Jan 05 2017 
    Kevin O’Leary’s Top 10 Quality Dividend Stocks Dec 29 2016 
    US Market Indexes Higher for the Week Dec 24 2016 
    Health Care Companies Showing Good Defensive Potential Dec 22 2016 
    Donald Yacktman Reduces Multiple Positions in 3rd Quarter Dec 21 2016 
    US Market Indexes Mixed on Monday Dec 12 2016 
    Tweedy Browne Fund Investment Adviser's Semi-Annual Letter to Shareholders Nov 28 2016 

    More From Other Websites
    Sanofi's M&A misses frustrate some investors in drugmaker Jan 20 2017
    Gilead, Merck, Alexion 2017 Views Hazy; Biogen May Surge: Analyst Jan 19 2017
    What to Expect from Johnson & Johnson’s 4Q16 Earnings Jan 19 2017
    Low-Yield Dividend Stocks Belong in Your Portfolio Jan 19 2017
    A Green Light on Bayer Jan 19 2017
    Deal of the Week : J&J Nears Actelion Takeover Despite Twists and Turns Jan 19 2017
    Ten Dividend Stocks To Own Forever And Get Rich Slowly Jan 18 2017
    What???s Ahead for Johnson & Johnson (JNJ) in Q4 Earnings? Jan 18 2017
    [$$] Pfizer warns of 'big challenge' ahead from strong dollar Jan 18 2017
    Does Luxottica Now Have A Monopoly On The Eyeglass Space? Jan 17 2017
    ‘Boring’ stocks get more exciting as Trump rally fades Jan 17 2017
    Why Bristol-Myers Squibb May Be a Merger Target Soon Jan 17 2017
    The Word on the Street: What Analysts Are Recommending for JNJ Jan 16 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)